Board of Directors

NYSCF's Board of Directors is made up of leaders in medicine, the arts and business. Their talents and experience, combined with an unwavering commitment to advancing stem cell research, guide the Foundation in realizing its mission to accelerate cures for the major diseases of our time through stem cell research.

Dr. Roy Geronemus, Director of the Laser & Skin Surgery Center of New York, is a Clinical Professor of Dermatology at the NYU Langone Medical Center where he has founded its laser program and served nine years as its Chief of Dermatologic and Laser Surgery.  He is also the Director of the Skin/Laser Division in the Department of Plastic Surgery at the New York Eye & Ear Infirmary.  He is presently the president of the American Society for Laser Medicine & Surgery and a past president of the American Society for Dermatologic Surgery.

He graduated from Harvard University and pursued his medical education at the University of Miami School of Medicine.  He trained in dermatology at the New York University Medical Center where he was the Chief Resident and subsequently underwent fellowship training in Mohs Micrographic Surgery and Cutaneous Oncology.

He has received the ASLMS Ellet Drake and Leon Goldman awards.
Susan L. Solomon is Chief Executive Officer and Co-Founder of The New York Stem Cell Foundation (NYSCF), a non-profit organization established in 2005 to accelerate cures through stem cell research.

A longtime health-care advocate, Ms. Solomon is a founding member and current President of NYAMR (New Yorkers for the Advancement of Medical Research), is on the Executive and Nominating Committee for the Alliance for Regenerative Medicine, is a member of the Board of Directors of the Regional Plan Association of NY, and she has been a member of the Board of Directors of the Juvenile Diabetes Research Foundation, New York Chapter. Ms. Solomon was also a member of the Strategic Planning Committee of the Empire State Stem Cell Board...

Margo Alexander

Margo Alexander
Margo Alexander is former Board Chair of Acumen Fund, an international philanthropy that invests in businesses serving the poor. She served nine years of Acumen's first ten years and continues to work with the organization as Chairman of the Social Impact Investing Committee.

Ms. Alexander is the retired Chairman and CEO of UBS Global Asset Management (previously, Mitchell Hutchins Asset Management). She spent thirty years in the financial industry at UBS/PaineWebber, beginning as a research analyst and later directing major businesses in equity research, sales and trading. At the time of the UBS acquisition in 2000 she was a member of the PaineWebber Executive Committee and retired in 2003 from UBS.

Ms. Alexander is a graduate of the University of California at Berkeley and the Harvard Graduate School of Business Administration, where she met her husband Robert Alexander.

Ms. Alexander is a member of the Boards of Haas School at Berkeley and its Corporate Responsibility Committee, and is a member of The Council on Foreign Relations.

Peggy Brim Bewkes has had a long and very distinguished career as a writer, director and producer in television and film journalism. After graduating in Yale College’s first class of women, she joined ABC Sports.  There she worked in all facets of sports journalism, including producing the first 80 “Up Close and Personal” Olympic athletes’ profiles. She then became a show producer for ABC News where, at the age of 26, she launched the ABC news magazine show 20/20. Also while at ABC News, she was a senior assistant to Roone Arledge, working closely with him on the recreation of ABC News, which subsequently became the premier news network. She won an Emmy Award winner for her work at 20/20 and is the recipient of the Writers Guild Award for Outstanding Television Documentary for producing a pioneering investigation on the Love Canal.

Marilyn G. Breslow was President, and Senior Portfolio Manager of W. P Stewart & Co., Inc., an investment advisory firm in New York City, where she worked from 1990 until May 2005.   She was also the Manager and Director of their U.S. Mutual Fund. She worked extensively in the Netherlands and Austria, where she was the Manager of two mutual funds for Spaengler Bank.   She was a General Partner of Concord Partners, the venture capital division of Dillon, Read & Co., from 1984 to 1990, and was also a Vice President of that investment bank. Prior to Dillon, Read & Co., she was Director of Worldwide Marketing Services at Polaroid Corporation in Boston, and was a management consultant and General Partner at ICF, Inc., and Peat, Marwick, Mitchell & Co., Inc. in Washington D.C.
 
She has been a member of the M.I.T. Council for the Arts since 1997...

Dr. Karen Burke is a dermatologist and research scientist.   She received her PhD in biophysics from Cornell University, Ithaca, and her MD from New York University Medical College.   She completed postdoctoral fellowships at Cornell University Medical College and The Rockefeller University, and residency in dermatology at the NYU Medical Center.   She is in private practice in New York City and on the faculties of Mt. Sinai Medical Center and Cabrini Medical Center.

Dr. Burke has written numerous articles and four books.   Her current research demonstrates the efficacy of topical and oral antioxidants inpreventing and reversing photoaging of the skin and in prevention of skin cancer...

David Carmel is Co-Founder of Carmel Asset Management, an investment fund managed similarly to the top university endowments. Formerly, heserved as Vice President for Business Development at StemCyte Inc., a leading cell therapy company with operations in the US, Taiwan, and India. Prior to joining StemCyte, he spent a year working on Proposition 71, the California Stem Cell and Cures Initiative, for which voters approved $3 billion in research funds.  

While still in college, David co-founded Jumpstart, a national service program that pairs college students one-on-one with preschoolers needing individual attention. A decade later, Jumpstart employs 80 full time staff and engages 2,500 college students in service to more than 10,000 children in 60 communities across 22 states...

Alan M. Cohen

Alan M. Cohen

Alan is head of Global Compliance at Goldman Sachs.  He serves as a vice chair of the Business Practices Committee and an ex-officio member of the Management Committee. Alan joined Goldman Sachs in 2004 as a partner.

Prior to joining the firm, Alan worked as a partner at O'Melveny & Myers since 1991, where he co-headed the White Collar and Regulatory Defense Practice and the New York Litigation Group. Prior to this, he was an assistant US attorney for the Southern District of New York for nine years, where his last assignment was as the chief of the Securities and Commodities Fraud Task Force.

Alan earned a BA in 1972 from Temple University, and both a PhD in 1976 and a JD, with highest honors, in 1979 from Rutgers University.

John L. Eastman

John L. Eastman
Mr. Eastman is a partner at Eastman & Eastman.  He served as a Trustee of Smith College from 1989 to 1999, as well as co-chair of Smith College $400 million capital campaign.  He currently serves as a Trustee of the American Museum of Natural History; Director of the American Society of Composers Authors and Publishers (ASCAP); Director of the National Music Publishers Association; and Director of Apple Corps Limited (Beatles).  He served as Director of United Television, Inc. from 1985 to 2001 and BHC Communications, Inc. from 1989 to 2001 (Chris-Craft Industries).  He is a member of the Council on Foreign Relations, as well as the Board of Visitors of Columbia University Medical Center.    Mr. Eastman earned a BA in 1961 from Stanford University and a JD from New York University Law School in 1964.
Paul Goldberger is a Contributing Editor at Vanity Fair. From 1997 through 2011 he served as the Architecture Critic for The New Yorker, where he wrote the magazine’s celebrated “Sky Line” column. He also holds the Joseph Urban Chair in Design and Architecture at The New School in New York City. He was formerly Dean of Parsons School of Design, a division of The New School. He began his career at The New York Times, where in 1984 his architecture criticism was awarded the Pulitzer Prize for Distinguished Criticism, the highest award in journalism.
 
He is the author of several books, most recently Why Architecture Matters, published in 2009 by Yale University Press; Building Up and Tearing Down: Reflections on the Age of Architecture, a collection of his architecture essays published in 2009 by Monacelli Press, and Christo and Jeanne-Claude, published in 2010 by Taschen. He is now at work on a full-length biography of the architect...
Dr. Zach W. Hall, a neurobiologist now retired, was from 2005-2007 the first President of the California Institute for Regenerative Medicine (CIRM), the state agency set up under Proposition 71 for funding stem cell research in California.   Previously (1994-1997), he served as Director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health (NIH).  
 
After leaving NIH, he was Executive Vice Chancellor at the University of California, San Francisco (UCSF), where his major responsibility was the development of the new 43 acre campus at Mission Bay.   In 2001-2002, he was President and CEO of EnVivo Pharmaceuticals, Inc., a start-up biotechnology company for the discovery and development of pharmaceuticals for neurodegenerative disease.   From 2002-2005, he was Senior Associate Dean for Academic Development and also Director of the Zilkha Neurogenetic Institute at the Keck School of Medicine of the University of Southern California.   Dr. Hall has made fundamental contributions to...

George Lazarus, MD, has enjoyed a distinguished career as a member of the US Air Force, a Pediatrician, and a Professor of Medicine. At Yale University, George was selected to Phi Beta Kappa, and he graduated summa cum laude. He entered medical school at the College of Physicians and Surgeons of Columbia University, ultimately specializing in Pediatrics. He interned and then completed his residency at the Babies Hospital of Columbia-Presbyterian Medical Center, where he was appointed Chief Resident in Pediatrics.

Dr. Richard J. Massey was President and Chief Operating Officer of BioVeris Corporation and, prior to that, co-Founder of IGEN International, Inc. BioVeris was an integrated healthcare company, based in Gaithersburg, Maryland, that developed proprietary diagnostics and vaccines. BioVeris was publicly traded and resulted from the merger between IGEN International, Inc. and F. Hoffmann-La Roche Ltd. Dr. Massey was a co-founder of IGEN International, Inc.
 
Dr. Massey managed the research and development programs, intellectual property portfolio and operations at IGEN International, Inc. and BioVeris from 1982 to 2004.   Prior to IGEN International, Inc., he was on the faculty of...

David K. Mitnick

David K. Mitnick

David K. Mitnick is the Founder and President of Domain Skate, LLC, an internet company that focuses on domain name arbitration disputes. Prior to starting Domain Skate, David spent ten years as an intellectual property lawyer with Amster Rothstein & Ebenstein LLP in New York, working on all phases of intellectual property law including trademark licensing and prosecution, copyright litigation and and internet law. Before becoming an attorney, David worked as a Finance Associate at the Sanwa Bank in the International and Project Finance Groups.

He serves as a Trustee of the Mai Family Foundation and as the Advisory Board Chairman of the Brooklyn Law School Trade Secrets Institute. An avid hockey fan and player, David coaches hockey through the organization Ice Hockey in Harlem in the wintertime. David earned his BA from the University of Wisconsin-Madison, and a JD from Brooklyn Law School. Married to Rebecca Mai, they reside in New York City with their three children.

Mary Elizabeth Bunzel (Emeritus)

Mary Elizabeth Bunzel (Emeritus)
In 2005, Mary Elizabeth Bunzel co-founded the New York Stem Cell Foundation (NYSCF) with Susan L. Solomon. In addition to NYSCF, she serves on the Board of Directors of the New York Chapter of the Juvenile Diabetes Research Foundation (JDRF) and has previously served as Chapter President. Ms. Bunzel is also the Senior State Leader in New York for JDRF International, acting as liaison for advocate efforts in New York City, Westchester and Long Island.
 
A former journalist who has written for newspapers throughout the United States and abroad, Ms. Bunzel also serves as a member of the Board of Trustees of the Nightingale-Bamford School in New York City and   Kenyon College in Gambier, Ohio. She is married to Jeffrey H. Bunzel, who runs U.S. Equity Capital Markets for Credit Suisse First Boston. The Bunzels have four children.

Carol Einiger is President of Post Rock Advisors, LLC, a private investment advisory firm based in New York. She founded Post Rock Advisors after serving from 1996 to 2005 as Chief Investment Officer of The Rockefeller University.

Ms. Einiger began her investment career at Goldman Sachs in 1971. She worked from 1973 to 1988 at The First Boston Corporation, becoming a Managing Director and Head of the Capital Markets Department, and from 1989 to 1992 at Wasserstein Perella & Co. as a Managing Director...

Janet Felleman (Emeritus)

Janet Felleman (Emeritus)

Janet Felleman was recently appointed the New York State Parks Commissioner and chair of the New York City Region.

Previously she was the CEO and President of American Show Advisors which creates, markets and develops trade shows and conferences. She was the founder and former CEO of Corporate Presentations, the corporate parent of LegalTech which was acquired by American Lawyer Media in 1998. Janet is a trustee of Central Synagogue and on the President's Council of Prep for Prep.

NYSCF Cell Images

You are here: About Us Boards & Councils Board of Directors